WASHINGTON — Researchers say the U.S. approved more new medicines in less time than Europe and Canada in the last decade, challenging long-standing criticisms that the Food and Drug Administration lags behind its peers in clearing important new drugs. Between 2001 and 2010, the FDA’s typical review of a new drug was about 15 percent faster than those by the European Medicines Agency and Health Canada, its foreign counterparts, according to a study published Wednesday by the New England Journal of Medicine.

BING NEWS:
  • FDA receives patient reports of depression, suicide after taking weight loss drugs
    The drugs are so popular the exclusive patent holder, Novo Nordisk, has been ramping up production to meet extraordinary demand. Because of those shortages, Etheridge was not able to get the drug made ...
    04/15/2024 - 10:52 am | View Link
  • Personalized cancer treatments based on testing drugs quickly leads to faster treatment, better outcomes
    Diana Azzam, Florida International University Despite many efforts to find better, more effective ways to treat cancer, it remains a leading cause of death by disease among children in the U.S. Cancer ...
    04/11/2024 - 5:13 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News